Monday, March 19, 2007

AtheroGenics Warns Results Will Disappoint

AtheroGenics Inc. (AGIX) warned of disappointing results for its late stage clinical trial of a heart disease treatment. The stock price plummeted $4.74 to close at $3.09.

0 Comments:

Post a Comment

<< Home